The latest price target for Sensus Healthcare (NASDAQ:SRTS) was reported by HC Wainwright & Co. on November 18, 2024. The analyst firm set a price target for $11.00 expecting SRTS to rise to within 12 months (a possible 53.85% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Sensus Healthcare (NASDAQ:SRTS) was provided by HC Wainwright & Co., and Sensus Healthcare maintained their buy rating.

There is no last upgrade for Sensus Healthcare

There is no last downgrade for Sensus Healthcare.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensus Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensus Healthcare was filed on November 18, 2024 so you should expect the next rating to be made available sometime around November 18, 2025.

While ratings are subjective and will change, the latest Sensus Healthcare (SRTS) rating was a maintained with a price target of $10.00 to $11.00. The current price Sensus Healthcare (SRTS) is trading at is $7.15, which is out of the analyst’s predicted range.